METHOCARBAMOL for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 10 adverse event reports in the FDA FAERS database where METHOCARBAMOL was used for Psoriasis.
Most Reported Side Effects for METHOCARBAMOL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 294 | 13.4% | 1 | 138 |
| Completed suicide | 277 | 12.6% | 276 | 99 |
| Toxicity to various agents | 166 | 7.5% | 133 | 90 |
| Drug hypersensitivity | 162 | 7.4% | 2 | 9 |
| Drug dependence | 130 | 5.9% | 10 | 90 |
| Drug abuse | 121 | 5.5% | 30 | 75 |
| Hypertension | 119 | 5.4% | 31 | 68 |
| Off label use | 105 | 4.8% | 6 | 70 |
| Respiratory depression | 104 | 4.7% | 0 | 90 |
| Nausea | 95 | 4.3% | 4 | 37 |
| Product use issue | 90 | 4.1% | 5 | 80 |
| Dizziness | 89 | 4.0% | 15 | 30 |
| Product prescribing error | 87 | 4.0% | 5 | 76 |
| Pain | 82 | 3.7% | 6 | 20 |
| Somnolence | 81 | 3.7% | 5 | 32 |
Other Indications for METHOCARBAMOL
Product used for unknown indication (1,023)
Muscle spasms (148)
Back pain (128)
Pain (108)
Muscle relaxant therapy (44)
Suicide attempt (34)
Child abuse (25)
Fibromyalgia (23)
Neck pain (21)
Hypertension (20)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)